Revive Therapeutics Considers Exploring Bucillamine For Treatment Of Monkeypox
Revive Therapeutics (CSE: RVV) is continuing its efforts into evaluating the uses of Bucillamine, disclosing yesterday an update to its
Read moreRevive Therapeutics (CSE: RVV) is continuing its efforts into evaluating the uses of Bucillamine, disclosing yesterday an update to its
Read moreSnowline Gold (TSXV: SGD) has again intersected long intervals of mineralization at its flagship Rogue Project, found in the Yukon.
Read moreTwo months after the initiation of creditor protection, the assets of Indiva Limited have been sold off, with SNDL Inc
Read moreRed Pine Exploration (TSXV: RPX) is reporting a substantial improvement in mineral resources at its flagship Wawa Gold project in
Read morePharmaDrug (CSE: PHRX) this morning revealed the strategic plans for its Sairiyo Therapeutics subsidiary in relation to the clinical development of PD-001, its patented formulation for an enteric-coated version of cepharanthine.
Read moreG Mining Ventures (TSX: GMIN) has received the last of the approvals required for commercial operations at its Tocantinzinho gold
Read moreFission Uranium (TSX: FCU) is reporting that it has completed the front end engineering design phase for its flagship PLS
Read morePlurilock Security (TSXV: PLUR) is reporting this morning that it has further solidified its balance sheet through the exercise of warrants by shareholders. The warrants exercised relate to a $5.5 million financing conducted by the company back in April.
Read moreAscend Wellness (CSE: AAWH-U) has terminated the employment of both its chief executive officer as well as its chief financial
Read moreSilver Tiger Metals (TSXV: SLVR) has completed a pre-feasibility drill program at its flagship El Tigre project in the Sonora
Read more